Company intelligence / Profile preview

NAYA Oncology

Aventura, Florida, United States

Ownership: Private
Development stage: Other

Overview

NAYA Oncology is the oncology-focused division of NAYA Biosciences, a clinical-stage biopharmaceutical company dedicated to developing next-generation immunotherapies. The company's primary focus is on its proprietary bispecific antibody platform, which aims to provide more effective treatments for patients with high unmet needs in cancer care. Its lead candidate, NY-303, is a GPC3 x CD3 bispecific antibody currently being developed for the treatment of hepatocellular carcinoma. Additionally, the company is advancing NY-338, a CD38 x CD3 bispecific antibody targeting multiple myeloma. Following its merger with INVO Bioscience, NAYA Biosciences operates as a public entity, combining its innovative oncology pipeline with a commercial-stage fertility business. The company seeks to leverage its unique portfolio to drive value in both the biotechnology and healthcare services sectors.

Therapeutic areas: Oncology
Modalities: Bispecific monoclonal antibodyMonoclonal antibody
Industry: Biotech

Beyond the preview

Go deeper on NAYA Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAYA Oncology.

Explore the full profile